MarketCap
Facebook
X
Telegram
Land |
 Schweiz |
IPO-Jahr |
2014 |
Branche |
Diagnostik & Forschung |
Börse |
NASDAQ GLOBAL |
Anteile |
102 M |
Marktkapitalisierung |
$ 1.1 M |
EBITDA (LTM) |
- |
P/E (LTM) |
- |
P/S (LTM) |
- |
EPS (LTM) |
- |
Andere Aktien der Branche "Diagnostik & Forschung"
| Name | Preis | % 24h | Marktkapitalisierung | Börse | Land | |
|---|---|---|---|---|---|---|
 |
Neuronetics
STIM
|
$ 2.93 | 1.74 % | $ 193 M | Nasdaq Global Select Market |  USA |
 |
Thermo Fisher Scientific
TMO
|
$ 603.02 | 0.02 % | $ 227 B | NYSE,SPB | USA |
 |
Twist Bioscience Corporation
TWST
|
$ 128.06 | 2.68 % | $ 7.66 B | Nasdaq Global Select Market,SPB | USA |
 |
Senseonics Holdings
SENS
|
$ 9.33 | 5.97 % | $ 389 M | NYSE American | USA |
 |
Sotera Health Company
SHC
|
$ 18.59 | 0.05 % | $ 5.28 B | Nasdaq Global Select Market | USA |
 |
VolitionRx Limited
VNRX
|
$ 0.33 | 2.52 % | $ 41.5 M | NYSE American |  Singapore |
 |
Waters Corporation
WAT
|
$ 402.91 | 0.33 % | $ 24 B | NYSE,SPB | USA |
 |
Exagen
XGN
|
$ 7.3 | 0.53 % | $ 157 M | Nasdaq Global Market | USA |
 |
Akumin
AKU
|
- | -17.87 % | $ 25.9 M | Nasdaq Capital Market |  Canada |
 |
Trinity Biotech plc
TRIB
|
$ 9.06 | 0.64 % | $ 3.25 B | Nasdaq Global Select Market |  Irlanda |
 |
Accelerate Diagnostics
AXDX
|
- | -61.36 % | $ 2.46 M | Nasdaq Global Select Market | USA |
 |
Biocept
BIOC
|
- | -13.05 % | $ 7.29 M | Nasdaq Capital Market | USA |
 |
Chembio Diagnostics
CEMI
|
- | 0.22 % | $ 16.8 M | Nasdaq Capital Market | USA |
 |
Heska Corporation
HSKA
|
- | - | $ 1.31 B | Nasdaq Capital Market,SPB | USA |
 |
HTG Molecular Diagnostics
HTGM
|
- | -20.0 % | $ 1.06 M | Nasdaq Capital Market | USA |
 |
Psychemedics Corporation
PMD
|
- | -1.84 % | $ 15.3 M | Nasdaq Global Select Market | USA |
 |
Quest Diagnostics Incorporated
DGX
|
$ 235.5 | 0.06 % | $ 26.1 B | NYSE,SPB | USA |
 |
Syneos Health
SYNH
|
- | - | $ 4.46 B | Nasdaq Global Select Market,SPB | USA |
 |
T2 Biosystems
TTOO
|
- | -39.35 % | $ 313 K | Nasdaq Global Select Market | USA |
 |
Meridian Bioscience
VIVO
|
- | - | $ 1.49 B | Nasdaq Global Select Market | USA |
 |
Motus GI Holdings
MOTS
|
- | -34.28 % | $ 263 K | Nasdaq Global Select Market |  Israel |
 |
Brainsway Ltd.
BWAY
|
$ 14.16 | 0.07 % | $ 481 M | Nasdaq Global Select Market | Israel |
 |
Renalytix AI plc
RNLX
|
- | 5.66 % | $ 22.7 M | Nasdaq Global Market |  Britain |
 |
DermTech
DMTK
|
- | -11.32 % | $ 2.94 M | Nasdaq Capital Market,SPB | USA |
 |
Quidel Corporation
QDEL
|
$ 13.38 | 0.29 % | $ 564 M | Nasdaq Global Select Market,SPB | USA |
 |
Precipio
PRPO
|
$ 27.25 | 0.11 % | $ 43.7 M | Nasdaq Global Select Market | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
- | - | $ 562 M | Nasdaq Global Select Market | Britain |
 |
Anixa Biosciences
ANIX
|
$ 2.9 | 0.66 % | $ 94.1 K | Nasdaq Capital Market | USA |
 |
Fluidigm Corporation
FLDM
|
- | 1.08 % | $ 308 M | Nasdaq Global Select Market | USA |
|
Biodesix
BDSX
|
$ 26.63 | 1.72 % | $ 201 M | Nasdaq Global Market | USA |
 |
Biomerica
BMRA
|
$ 2.34 | 1.3 % | $ 6.82 M | Nasdaq Capital Market | USA |
 |
BioNano Genomics
BNGO
|
$ 1.2 | 1.25 % | $ 6.53 M | Nasdaq Capital Market,SPB | USA |
 |
Burning Rock Biotech Limited
BNR
|
$ 10.71 | 11.22 % | $ 113 M | Nasdaq Global Market |  China |
 |
PRA Health Sciences, Inc.
PRAH
|
- | - | $ 10.7 B | Nasdaq Global Select Market | USA |
 |
Agilent Technologies
A
|
$ 146.85 | 0.59 % | $ 41.7 B | NYSE,SPB | USA |
|
Centogene N.V.
CNTG
|
- | -6.23 % | $ 30.6 M | Nasdaq Global Market |  Germany |
 |
Global Cord Blood Corporation
CO
|
- | - | $ 399 M | NYSE | China |
 |
Genetic Technologies Limited
GENE
|
- | - | $ 7.1 B | Nasdaq Capital Market |  Australia |
 |
Genetron Holdings Limited
GTH
|
- | 0.12 % | $ 80.1 M | Nasdaq Global Market | China |
 |
Bioventus
BVS
|
$ 13.83 | 0.42 % | $ 921 M | Nasdaq Global Select Market | USA |
 |
CareDx, Inc
CDNA
|
$ 50.31 | 2.05 % | $ 2.68 B | Nasdaq Global Market,SPB | USA |
 |
Celcuity
CELC
|
$ 93.02 | 0.75 % | $ 4.35 B | Nasdaq Global Select Market | USA |
 |
Co-Diagnostics
CODX
|
$ 1.12 | 2.55 % | $ 1.49 M | Nasdaq Capital Market | USA |
 |
Charles River Laboratories International
CRL
|
$ 280.76 | 0.54 % | $ 13.9 B | NYSE,SPB | USA |
 |
Castle Biosciences
CSTL
|
$ 32.76 | 1.03 % | $ 950 M | Nasdaq Global Market,SPB | USA |
 |
Danaher Corporation
DHR
|
$ 205.23 | 0.53 % | $ 146 B | NYSE,SPB | USA |
 |
DarioHealth Corp.
DRIO
|
$ 7.03 | 3.72 % | $ 28 M | Nasdaq Capital Market | Israel |
 |
DexCom
DXCM
|
$ 84.53 | 0.02 % | $ 33 B | Nasdaq Global Select Market,SPB | USA |
 |
Fulgent Genetics
FLGT
|
$ 20.2 | 2.38 % | $ 622 M | Nasdaq Global Market | USA |